Overview

The Dose-response "Pilot" Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
To determine the dose-response relationship for Clobex TM (clobetasol propionate) Lotion, 0.05%. This information will be used to estimate the ED50, D1, D2 parameters for use in a full bioequivalence study.
Phase:
Phase 1
Details
Lead Sponsor:
Actavis Inc.
Treatments:
Clobetasol